Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer

Liqing Lu1,2, Ye Zhang2, Xuemei Tan3

  • 1Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.

Cell Death Discovery
|July 27, 2022
PubMed

Insights

Pyroptosis, an inflammatory cell death, is linked to cancer. This review explores pyroptosis mechanisms, its role in tumors, and its therapeutic potential using chemotherapy, natural compounds, and nanotechnology for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Pyroptosis is an inflammatory programmed cell death pathway.
  • It is initiated by caspase cleavage of gasdermin proteins.
  • Pyroptosis is increasingly implicated in tumor development, but its precise role and mechanisms remain under investigation.

Purpose of the Study:

  • To review the definition, characteristics, and activation pathways of pyroptosis.
  • To elucidate the complex role of pyroptosis in various cancers.
  • To summarize therapeutic strategies targeting pyroptosis in cancer treatment.

Main Methods:

  • Literature review of pyroptosis mechanisms and cancer associations.
  • Analysis of studies on pyroptosis in tumor development and immunity.
  • Compilation of data on FDA-approved drugs, natural compounds, and nanotechnology inducing pyroptosis.

Main Results:

  • Pyroptosis plays a multifaceted role in tumor progression and anticancer immunity.
  • Several FDA-approved chemotherapy drugs and natural compounds induce antitumor effects by triggering pyroptosis.
  • Nanotechnology offers a promising approach for pyroptosis-based tumor therapy.

Conclusions:

  • Understanding pyroptosis is crucial for developing novel cancer therapies.
  • Targeting pyroptosis pathways holds significant therapeutic potential for various cancers.
  • Further research into pyroptosis mechanisms and applications is warranted.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K